From theheart.org on Medscape

Coverage from the

American College of Cardiology (ACC) 2016 Scientific Sessions

April 02 - 04, 2016; Chicago, Illinois

April 02 - 04, 2016 Chicago, Illinois

Visit us at Booth #1013

The Cardiology Show

The Cardiology Show From ACC 2016 With Dr Valentin Fuster UPDATED with Transcript // HOPE-3 and trials covering transcatheter aortic valves, FH mutations, and mobile health are the main focus of the discussion from a chilly Chicago.

MEETING HIGHLIGHTS AT A GLANCE

Top News From ACC 2016: Slideshow More than two dozen late-breaking clinical trials and featured research presentations greeted attendees, including new data on statins, atrial fibrillation, and heart failure.

Conference News

ACC ATMOSPHERE: Aliskiren Not Superior to Enalapril in HF
Heartwire from Medscape, April 20, 2016
ACC In-Hospital TAVR Outcomes Improve as Case Volume Goes Up
Heartwire from Medscape, April 18, 2016
ACC CoreValve High-Risk Study at 3 Years: TAVR Advantage Sustained
Heartwire from Medscape, April 15, 2016
ACC Sex Matters in the Diagnostic Performance of CAD Testing
Heartwire from Medscape, April 15, 2016
ACC High Troponin Levels Associated With Mental-Stress Ischemia
Heartwire from Medscape, April 15, 2016
ACC Surgery Tops Drugs for Glycemic Control at 5 Years: STAMPEDE
Heartwire from Medscape, April 14, 2016
ACC Rapid HF Readmission Program Curbs Costs
Heartwire from Medscape, April 14, 2016
ACC Vitamin D Boosts LVEF, Not Walk Distance, in HF Study
Heartwire from Medscape, April 13, 2016
ACC Radial Access for PCI Seems to Cut Contrast-Nephropathy Risk
Heartwire from Medscape, April 12, 2016
ACC Patients Often Unaware of ICD Issues Near End of Life
Heartwire from Medscape, April 12, 2016
ACC Type 2 'Supply-Demand' MI More Common, Lethal Than Appreciated
Heartwire from Medscape, April 11, 2016
ACC Worldwide Virtual 'Race' Keeps Adults Moving, Off Chairs
Heartwire from Medscape, April 11, 2016
ACC Calls for Higher Heparin-Dosing Caps in Obese With ACS
Heartwire from Medscape, April 11, 2016
ACC Selective Valve Repair at CABG in Moderate Ischemic MR
Heartwire from Medscape, April 8, 2016
ACC Empowered Pharmacists Lower Patients' Cardiac Risk in RxEACH
Heartwire from Medscape, April 7, 2016
ACC Shared Decision Making in Low-Risk Chest Pain: Safe, Fewer Tests
Heartwire from Medscape, April 7, 2016
ACC ALPS: No Overall Survival Increase From Amiodarone, Lidocaine
Heartwire from Medscape, April 7, 2016

ACC Marijuana Use Before Acute MI May Give Survival Edge in Hospital
Heartwire from Medscape, April 6, 2016
ACC Stem-Cell Therapy Improves Clinical Outcomes in Heart Failure
Heartwire from Medscape, April 5, 2016
ACC 'Food Desert' Dwellers Have Worse Heart-Disease Risk Profiles
Heartwire from Medscape, April 5, 2016
ACC TAVR Superior to Surgery in Intermediate-Risk Patients: SAPIEN 3
Heartwire from Medscape, April 5, 2016
ACC FIRE and ICE: Cryoablation Matches RF Ablation in PAF
Heartwire from Medscape, April 4, 2016
ACC STICHES: CABG Boosts 10-Year Survival in Severe LV Dysfunction
Heartwire from Medscape, April 4, 2016
ACC Deferred Stenting, Postconditioning Strike Out in STEMI: DANAMI 3
Heartwire from Medscape, April 4, 2016
ACC Rhythm vs Rate Control: A Toss-up for Postoperative AF
Heartwire from Medscape, April 4, 2016
ACC Very High LDL Seldom Caused By FH Gene Variants
Heartwire from Medscape, April 3, 2016
ACC Morphine at Acute MI May Blunt Short-Term Antiplatelet Response
Heartwire from Medscape, April 3, 2016
ACC GAUSS-3: Evolocumab Cuts LDL-C in Statin-Intolerant Patients
Heartwire from Medscape, April 3, 2016
ACC HOPE-3: Statins Lower CV Events in Intermediate-CHD-Risk Patients
Heartwire from Medscape, April 2, 2016
ACC PARTNER 2 Backs TAVR in Intermediate-Risk Patients
Heartwire from Medscape, April 2, 2016
ACC PPIs May Lower GI Events After DAPT With Low-Dose Aspirin
Heartwire from Medscape, March 29, 2016
ACC The ACC 2016 Scientific Sessions and All That Jazz: A Preview
Heartwire from Medscape, March 28, 2016
ACC Breast Calcification on Mammography IDs CVD Risk
Heartwire from Medscape, March 25, 2016

News at a Glance

Technology Rekindling the Doctor-Patient Relationship Note bloat and the antisocial manner of some electronic health record keepers has given digital tools a bad rap, according to experts who say social media is powering a revolution in healthcare.
Medscape Medical News, April 4, 2016
Women's Heart Health Hindered by Social Stigma About Weight Cardiovascular disease is the number one killer of American women, yet too few are screened by their physicians, according to a report that says that women are embarrassed by the diagnosis.
Medscape Medical News, April 3, 2016
Pricey PCSK9 Inhibitors Require Careful Patient Selection The drugs, for familial hypercholesterolemia and atherosclerotic cardiovascular disease, cost about $14,000/year in the US, even though the effect on morbidity and mortality has yet to be determined.
Medscape Medical News, April 1, 2016
Population Health, HOPE, and PARTNER Raise Curtain at ACC The American College of Cardiology 2016 Scientific Session will open with the Simon Dack Lecture on population health and results from the HOPE-3 trial and the PARTNER 2 study.
Medscape Medical News, March 31, 2016

Perspectives from ACC

Dean Ornish on Love and Connection (the Touchy-Feely Stuff)
Tricia Ward
Dean Ornish in Defense of the Dietary Fat – Heart Disease Link
Tricia Ward
Five Key Cardiology Lessons for Primary Care: ACC 2016
Laurie Scudder, DNP, NP
ATMOSPHERE and the RAS Blockade Ceiling in Heart Failure
Ileana L. Piña, MD, MPH
Rate vs Rhythm for Post-op AF: Neutral Trial, Positive Message
John M. Mandrola, MD
HOPE-3 Blood Pressure and Lipid Lessons for Practice
Clyde W. Yancy, MD, MSc; Jennifer G. Robinson, MD, MPH
PCSK9 Inhibitors for Statin Intolerance, Early Beta Blockade in AMI?
Robert A. Harrington, MD; E. Magnus Ohman, MD

Live Blog

News and Views from ACC 2016 Coverage of key advances and expert reactions as they happened at the meeting.

Bloggers from the Floor

Pivoting to Prevention and Population Health: Not an Easy Pill to Swallow Dr John Mandrola distills the essence of the Simon Dack lecture and reflects on what it means for cardiology.
If Shared Decisions Can Make It in the ED, They Can Make It Anywhere Dr John Mandrola recounts the results of the Chest Pain Choice Trial, where low-risk patients in the emergency helped make the decision on how to proceed.
Post-Cardiac Surgery Atrial Fibrillation and the Wisdom of Voltaire Dr John Mandrola discusses rate control vs rhythm control after cardiac surgery in light of a new study presented here at ACC 2016.
HOPE-3: Is It Time to Hate the Polypill Concept Less? Dr Walton-Shirley ruminates on HOPE-3 and reflects on the balance of risks and benefits of treatment without extreme scrutiny.
High Value for Vascular Care? Perhaps Not for Some Dr Melissa Walton-Shirley sits in on a session on peripheral vascular care and finds out that too much is spent as well as not enough, that some are overtreated and others ignored.

Pre-Meeting Commentary

Mandrola Previews American College of Cardiology 2016 Meeting
John Mandrola, MD

PRE-MEETING TOPIC REVIEW

PCSK9 Inhibitors: A Brief Primer
Merle Myerson, MD, EdD
TAVR in the US: Matured or Still Evolving?
Tricia Ward

Medscape Board at the Podium

Samuel Goldhaber, MD Harvard Medical School, Boston, Massachusetts
Robert Harrington, MD Stanford University, Stanford, California
Roxana Mehran, MD Icahn School of Medicine, Mount Sinai, New York

Journalists

Steve Stiles
News Editor
Patrice Wendling
Senior Journalist
Deborah Brauser
Journalist

Previous Coverage